4187 — Osaka Organic Chemical Industry Balance Sheet
0.000.00%
- ¥49bn
- ¥43bn
- ¥33bn
- 90
- 71
- 45
- 81
Annual balance sheet for Osaka Organic Chemical Industry, fiscal year end - November 30th, JPY millions except per share, conversion factor applied.
2020 November 30th | 2021 November 30th | 2022 November 30th | 2023 November 30th | 2024 November 30th | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | Yuho | Yuho | Yuho | Yuho | Yuho |
Standards: | JAS | JAS | JAS | JAS | JAS |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 7,722 | 9,924 | 8,095 | 7,891 | 13,048 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 8,152 | 9,460 | 10,167 | 8,957 | 11,608 |
Total Inventory | |||||
Total Other Current Assets | |||||
Total Current Assets | 23,134 | 28,089 | 28,082 | 27,102 | 34,287 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 16,299 | 15,610 | 18,471 | 20,443 | 18,415 |
Net Goodwill | |||||
Net Intangible Assets | |||||
Long Term Investments | |||||
Other Long Term Assets | |||||
Total Assets | 45,324 | 49,868 | 52,837 | 54,637 | 59,965 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 7,554 | 8,688 | 9,170 | 7,098 | 11,730 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Minority Interest | |||||
Total Other Liabilities | |||||
Total Funded Status | |||||
Total Liabilities | 10,666 | 11,223 | 12,010 | 11,653 | 14,529 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Treasury Stock | |||||
Unrealized Gain / Loss | |||||
Other Equity | |||||
Total Equity | 34,658 | 38,646 | 40,826 | 42,984 | 45,435 |
Total Liabilities & Shareholders' Equity | 45,324 | 49,868 | 52,837 | 54,637 | 59,965 |
Total Common Shares Outstanding |